Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure

Description

To describe and compare the symptom burden in cancer patients with concurrent diagnosis of heart failure (HFrEF compared to HFpEF).

Conditions

Heart Failure

Talk to us

Study Overview

On this page

Study Details

Study overview

To describe and compare the symptom burden in cancer patients with concurrent diagnosis of heart failure (HFrEF compared to HFpEF).

Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure

Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure

Condition
Heart Failure
Intervention / Treatment

-

Contacts and Locations

Houston

The University of Texas of MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 years and older
  • * Individuals with a concurrent solid tumor cancer diagnosis
  • * Not receiving active cancer treatment except for those on maintenance (i.e., Selective ER modulators (SERMs)\[Tamoxifen\], Aromatase inhibitors (Anastrozole, Letrozole, Exemestane), Ovarian suppression therapy (GnRH Agonists \[Leuprolide\], Androgen deprivation therapy for prostate cancer
  • * Completed cancer treatment at least 3 months and up to 3 years before study enrollment.
  • * Able to read, speak and consent in English
  • * Ability to understand and the willingness to sign a written informed consent document
  • * Diagnosis of heart failure, confirmed by echocardiogram, MUGA, or cardiac catheterization
  • * Internet access via smart phone, tablet, a computer, or another device with the capacity to 1) download the Fitbit App and 2) complete electronic study assessments via REDCap.
  • * Participants undergoing active cancer treatment.
  • * Inability to provide consent in the medical record, such as cognitively impaired individuals.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Study Record Dates

2028-09-01